Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bogdan
    Member
    • Jul 2008
    • 35

    RNA-seq and PET-seq

    Hello everyone.

    The question may have been answered already : I am looking for a list of packages I could use for Illumina paired - end sequencing analysis or/and for mRNA sequencing analysis.
    Any suggestions would be much appreciated. Thanks,

    thanks very much,

    bogdan
  • Colinmt
    Junior Member
    • Feb 2009
    • 2

    #2
    We've been using the CLC bio genomics workbench software package. Downside is you have to pay for it. Upside - its very, very comprehensive and should cover all of your needs.

    Comment

    • bogdan
      Member
      • Jul 2008
      • 35

      #3
      free software

      Thanks Colin. I would prefer to use some free software though, if it is available. Thanks !

      Comment

      • Melissa
        Senior Member
        • Aug 2008
        • 124

        #4
        Most software that can handle illumina reads can support PE reads. I'll let other more experienced members to give you the list. Don't worry. There's a long list of freeware. It depends on what kind of mRNA-seq analysis (de novo assembly, gene expression, microRNA etc?).

        I haven't heard about any that is good with RNA-seq de novo assembly. Any idea?

        Melissa

        Comment

        • bogdan
          Member
          • Jul 2008
          • 35

          #5
          Hi Melissa,

          we are doing mRNA-seq. There are some packages as ERANGE and RSAT :
          did these work very well? thanks,

          bogdan

          Comment

          • Cole Trapnell
            Senior Member
            • Nov 2008
            • 213

            #6
            You might try my TopHat tool (http://tophat.cbcb.umd.edu), which now supports both paired ends and longer read lengths. It's still in "beta", but you might find it helpful. It will align RNA-Seq reads across splice junctions without needing a reference annotation (but if you have one, you can use it).

            Comment

            • bogdan
              Member
              • Jul 2008
              • 35

              #7
              TopHat

              Hi Cole,

              yes, I did install the package you did make. it works great on the test data, and will apply to our data soon. A question though : are there any options/parameters I shall use in order to
              output the quantitative expression instead of the splice junctions ? thanks a lot,

              bogdan

              Comment

              • Cole Trapnell
                Senior Member
                • Nov 2008
                • 213

                #8
                You'll need a GFF file for the RPKM calculation, but as far as parameters go, the defaults should be fine if you are working with a mammalian genome. If you're not, I'd recommend dropping down the maximum ab initio intron length (the -I param) to a few Kb for your first run, just to get a conservative idea of how TopHat performs.

                If you don't want TopHat to look for junctions ab initio at all, you can use --no-novel-juncs to put TopHat in a "validate only" mode, where it will just try to align your RNA-Seq reads across the junctions in your GFF file (or your raw junctions file if you use the -j option).

                Comment

                • bogdan
                  Member
                  • Jul 2008
                  • 35

                  #9
                  Thanks, Cole. Will proceed accordingly. If I have any other questions, perhaps I can contact you directly ? And congrats for the work ! The packages and the algorithms are designed in a very professional way !

                  Comment

                  • Cole Trapnell
                    Senior Member
                    • Nov 2008
                    • 213

                    #10
                    Yes, please feel free to contact me directly (cole AT cs DOT umd DOT edu). Good luck!

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      07-20-2026, 11:48 AM
                    • SEQadmin2
                      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by SEQadmin2



                      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                      ...
                      07-09-2026, 11:10 AM
                    • SEQadmin2
                      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                      by SEQadmin2



                      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                      07-08-2026, 05:17 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 07-24-2026, 12:17 PM
                    0 responses
                    29 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-23-2026, 11:41 AM
                    0 responses
                    21 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-20-2026, 11:10 AM
                    0 responses
                    211 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-13-2026, 10:26 AM
                    0 responses
                    78 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...